表 4.
CD8+T淋巴细胞与临床实验室指标之间的关系
Relationship between CD8+T lymphocyte cells reduction and clinical laboratory index
| Reduction group (n=15) | Normal group (n=17) | P | |
| Abbreviations as in Table 3. | |||
| Age/years，x±s | 47.76±13.79 | 53.73±13.10 | 0.221 |
| Women，n(%) | 15 (100) | 16 (94.12) | 0.531 |
| Disease duration/years，M(P25, P75) | 4 (0.5，20) | 6.5 (1，28) | 0.189 |
| Raynaud‘s phenomenon，n(%) | 12 (70.59) | 14 (93.33) | 0.178 |
| Diffuse cutaneous changes，n(%) | 13 (76.47) | 12 (80) | 0.355 |
| fingertip ulcer，n(%) | 3 (17.65) | 4 (26.66) | 0.678 |
| Pulmonary interstitial fibrosis，n(%) | 12 (70.59) | 11 (73.33) | 1.000 |
| ANA，n(%) | 14 (93.33) | 15 (88.24) | 1.000 |
| Scl-70, n(%) | 5 (33.33) | 6 (35.29) | 1.000 |
| ESR/(mm/h), M(P25, P75) | 23.00 (11.50，27.50) | 9.00 (7.50，17.00) | 0.022 |
| CRP/(mg/L), M(P25, P75) | 7.15 (0.71，12.83) | 2.43 (0.55，3.14) | 0.142 |
| IgG/(g/L), M(P25, P75) | 13.50 (9.30，16.40) | 11.20 (9.50，15.70) | 0.551 |
| IgM/(g/L), M(P25, P75) | 0.77 (0.52，0.94) | 0.91 (0.72，1.18) | 0.370 |
| IgA/(g/L), x±s | 1.96±1.27 | 2.39±1.48 | 0.387 |
| C3/(g/L), x±s | 0.87±0.20 | 0.88±0.21 | 0.940 |
| C4/(g/L), x±s | 0.20±0.07 | 0.18±0.08 | 0.520 |